![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
![[thumbnail of Supplementary Data]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Data)
114MB |
| Item Type: | Article |
|---|---|
| Title: | Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease |
| Creators: |
Arlt, Friederike A.  ORCID: https://orcid.org/0000-0002-0112-8685, Miske, Ramona, Appeltshauser, Luise ORCID: https://orcid.org/0000-0001-5248-4009, Zinnow, Viktoria, Borowski, Kathrin, Stenzel, Werner, Radbruch, Helena, Meisel, Andreas ORCID: https://orcid.org/0000-0001-7233-5342, Ruprecht, Klemens, Endres, Matthias ORCID: https://orcid.org/0000-0001-6520-3720, Blau, Igor, Kirchner, Marieluise ORCID: https://orcid.org/0000-0002-7049-534X, Mertins, Philipp ORCID: https://orcid.org/0000-0002-2245-528X, Sanchez-Sendin, Elisa, Wernick, Stephanie, Pressler, Hannah, Stascheit, Frauke ORCID: https://orcid.org/0000-0001-5306-7880, Linke, Janis, Hümmert, Sophie, Werner, Hauke B., Wibisono, Esravila A., Doppler, Kathrin, Komorowski, Lars, Spiliotis, Elias T., Dubey, Divyanshu, Zeckeridou, Anastasia, Pittock, Sean J. ORCID: https://orcid.org/0000-0002-6140-5584, Mills, John R., McKeon, Andrew ORCID: https://orcid.org/0000-0001-6856-8143, Scharf, Madeleine and Prüss, Harald ORCID: https://orcid.org/0000-0002-8283-7976
|
| Abstract: | Severe neuropathies with predominant involvement of motor fibres can resemble lower motor neuron disease (LMND) phenotypes. Given the fatal prognosis of LMND, identifying underlying autoimmune syndromes is crucial to provide treatment options to patients. We investigated a novel autoantibody binding pattern observed on murine teased sciatic nerve fibres. Target antigens were identified using immunoprecipitation combined with mass spectrometry. Target specificity of these autoantibodies was validated in cell-based assays, neutralization assays and knock-out models. A retrospective study cohort consisting of different neuropathies (chronic inflammatory demyelinating polyradiculopathy n = 86, Guillain–Barré syndrome n = 37, multifocal motor neuropathy n = 18, diabetic neuropathy n = 30, other inflammatory neuropathies n = 10), amyotrophic lateral sclerosis (n = 50), multiple sclerosis (n = 50) and healthy controls (n = 50) was negative for septin multimer autoantibodies. Histopathological analysis of skin and the sural nerve including electron microscopy was performed in one seropositive patient, and autoantibody binding was characterized in vitro. Extensive immunotherapy was initiated in one patient, with clinical and serological follow-up over 4 years. Among 3543 total samples tested, three patients (two male, one female)—diagnosed with the LMND variant of amyotrophic lateral sclerosis (aged 65, 72 and 79 years, respectively)—showed a novel and distinct autoantibody binding pattern of indirect immunofluorescence staining on peripheral nerves, targeting Schmidt–Lanterman incisures (SLIs), paranodes and the abaxonal myelin. Target identification and validation revealed septin multimers as autoantibody epitopes. Despite the primarily intracellular location of septins, autoantibody binding was evident in living myelinated dorsal root ganglia, primarily at SLIs (‘incisuropathy’). Septin multimer autoantibodies further initiated complement deposition on fixed and permeabilized cell-based assays. Sural nerve and skin biopsies showed inflammation, myelin and axonal pathology. Extensive immunotherapy in one patient was followed by disease stabilization over 3 years. The other two patients died of rapid disease progression: one of them received no immunotherapy while the other had ineffective treatments with single administrations of intravenous immunoglobulin and rituximab. Our data suggest that septin multimer autoimmunity occurs in severe motor-predominant neuropathies which can clinically resemble a neurodegenerative LMND. Screening for septin multimer autoantibodies should be considered in patients presenting with this phenotype. Follow-up studies need to determine the direct pathogenicity of septin multimer autoantibodies, their potential as a biomarker of an autoimmune syndrome and responses to immunotherapy in larger cohorts. |
| Keywords: | Motor Neuron Autoimmunity, Autoantibody Discovery, Teased Fiber Assay, Peripheral Nerve Inflammation, Animals, Mice |
| Source: | Brain |
| ISSN: | 0006-8950 |
| Publisher: | Oxford University Press |
| Volume: | 149 |
| Number: | 8 |
| Page Range: | 2731-2746 |
| Date: | August 2026 |
| Official Publication: | https://doi.org/10.1093/brain/awag183 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
